Document is current
Any future updates will be listed below
-
Authors
Sharifan, Amin https://orcid.org/0000-0003-0571-5964
Sivaprasad, Sobha
- License Information
-
More Information
Article History
Received: 19 August 2024
Revised: 30 August 2024
Accepted: 13 September 2024
First Online: 17 September 2024
Competing interests
: AS holds an unpaid position as a steering member of the Cochrane Early Career Professionals Network. He reports complimentary access to the Cochrane Database of Systematic Reviews for writing Cochrane Clinical Answers and to Scopus for reviewing manuscripts for journals published by Elsevier. SS is the Editor in Chief of Eye and reports receipts of financial support from AbbVie, Alimera Science, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Clearside Biomedical, Eyebiotech, Eyepoint Phamaceuticals, Iveric Bio, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Ripple Therapeutics, Roche, Stealth Biotherapeutics and Sanofi.
